ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
3,1,Bronchopulmonary dysplasia,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,Y
4,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
4,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
5,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
5,2,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
5,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,5,Visual field defect,Visual field disorders,Vision disorders,Eye,N
6,1,Semen analysis abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
7,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
8,1,Semen analysis abnormal,Fertility analyses and other reproductive function procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
9,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
9,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
12,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
13,1,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
14,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
15,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
16,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
16,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
16,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
17,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
17,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
17,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
18,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
19,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
19,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
20,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
21,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
22,1,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
22,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
24,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
24,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
25,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
25,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
26,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
26,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
26,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
28,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
28,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
28,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
30,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
31,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
31,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
32,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
33,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
33,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
33,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
34,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
34,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
34,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
35,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
36,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
37,1,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
38,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
38,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
38,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
39,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
39,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
39,3,Headache,Headaches NEC,Headaches,Nerv,N
40,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
41,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
42,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
43,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
43,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
44,1,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
45,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
47,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
47,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
48,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
49,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
49,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
50,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
51,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
52,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
52,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
52,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
53,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
54,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
54,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
55,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
55,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
55,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
55,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
56,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
57,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
57,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
57,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
58,1,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
59,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
59,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
59,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
60,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
61,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
62,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
62,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
63,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
64,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
64,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
64,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
64,4,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
65,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
65,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
65,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
65,5,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
65,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
67,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
67,2,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,Y
67,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
69,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
70,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
71,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
72,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
73,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
74,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
75,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
76,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
76,2,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
77,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
77,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
78,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
78,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
78,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
78,4,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
79,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
80,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
81,1,Headache,Headaches NEC,Headaches,Nerv,N
81,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
83,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
83,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
83,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
83,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
84,1,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
84,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
84,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
84,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
84,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
85,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
86,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
86,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
87,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
87,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
87,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
87,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
87,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
87,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
87,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
88,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
89,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
90,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
90,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
91,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
91,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
91,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,Y
93,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
93,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
94,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
95,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
95,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
96,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
97,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
98,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
98,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
99,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
100,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
101,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
101,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
101,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
102,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
103,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
104,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
104,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
105,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
105,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
105,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
105,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
105,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
106,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
106,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
106,3,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
106,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
106,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
106,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
107,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
107,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
108,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
109,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
109,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
110,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
110,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
111,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
111,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
112,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
112,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
112,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
112,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
113,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
113,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
113,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
114,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
114,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
115,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
115,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
115,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
116,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
117,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
118,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
118,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
118,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
119,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
120,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
120,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
121,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
122,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
122,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
122,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
122,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
123,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
123,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
123,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
123,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
123,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
124,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
124,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
124,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
125,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
125,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
125,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
125,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
126,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
127,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
127,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
129,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
129,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
129,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
130,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
131,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
132,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
133,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
133,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
133,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
133,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
134,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
135,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
135,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
135,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
135,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
135,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
136,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
137,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
137,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
137,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
139,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
140,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
141,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
141,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
142,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
142,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
142,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
142,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
142,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
143,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
143,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
143,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
143,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
143,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
143,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
144,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
145,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
145,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
146,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
146,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
147,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
148,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
149,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
149,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
149,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
150,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
150,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
150,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
150,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
151,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
152,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
153,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
153,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
153,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
153,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
154,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
154,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
155,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
156,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
157,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
158,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
158,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
158,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
159,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
159,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
159,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
160,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
160,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
160,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
161,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
162,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
162,2,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
162,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
162,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
162,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
163,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
164,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
164,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
164,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
164,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
165,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
166,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
167,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
167,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
167,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
168,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
168,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
168,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
168,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
168,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
169,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
170,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,1,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
172,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
172,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
172,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
173,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
174,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
174,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
174,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
175,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
176,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
176,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
176,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
177,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
178,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
179,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
179,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
180,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
181,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
181,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
181,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
181,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
182,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
182,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
183,1,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
183,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
184,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
184,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
184,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
184,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
185,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
185,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
185,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
185,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
186,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
186,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
186,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
186,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
187,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
188,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
188,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
189,1,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
189,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
190,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
191,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
192,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
192,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
192,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
193,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
194,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
195,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
195,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
195,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
196,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
197,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
198,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
198,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
198,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
199,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
200,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
200,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
200,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
201,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
201,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
201,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
202,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
203,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
204,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
204,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
205,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
205,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
205,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
206,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
206,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
207,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
207,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
207,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
208,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
209,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
209,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
209,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
209,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
210,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
210,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
210,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
210,4,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
210,5,Lymph node abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
210,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
210,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
210,8,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
211,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
211,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
212,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
213,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
214,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
215,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
215,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
216,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
217,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
217,2,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
217,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
217,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
217,5,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
217,6,Reticulocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
217,7,Spherocytic anaemia,Red cell membrane and enzyme abnormalities,Haemolyses and related conditions,Blood,N
218,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
218,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
219,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
219,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
219,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
220,1,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
221,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
222,1,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
222,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
222,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
222,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
223,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
223,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
223,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
223,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
223,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
224,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
224,2,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
225,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
225,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
225,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
226,1,Anal cancer,Anal canal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
226,2,Anal skin tags,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
226,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
226,4,Spleen disorder,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
227,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
228,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
228,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
229,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
230,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
230,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
230,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
230,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
230,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
230,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
230,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
230,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
231,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
231,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
231,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
231,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
231,5,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
231,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
232,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
232,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
233,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
234,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
235,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
235,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
235,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
235,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
236,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
236,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
236,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
236,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
236,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
236,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
237,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
237,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
237,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
237,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
238,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
238,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
238,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
238,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
238,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
239,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
239,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
239,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
239,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
240,1,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
241,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
242,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
243,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
244,1,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
244,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
244,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
244,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
245,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
247,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
248,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
248,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
249,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
249,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
249,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
249,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
249,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
249,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
249,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
249,8,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
250,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
250,2,Headache,Headaches NEC,Headaches,Nerv,N
250,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
250,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
251,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
251,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
251,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
252,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
252,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
252,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
252,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
253,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
253,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
253,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
253,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
254,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
255,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
255,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
255,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
255,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
256,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
256,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
257,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
257,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
258,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
258,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
258,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
259,1,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
259,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
259,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
259,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
260,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
261,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
261,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
261,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
262,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
263,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
263,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
263,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
263,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
264,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
265,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
265,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
265,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
266,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
267,1,Salivary gland cancer,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
268,1,Metastases to salivary gland,Metastases to specified sites,Metastases,Neopl,N
269,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
270,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
271,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
271,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
271,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
272,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
273,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
273,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
274,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
274,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
275,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
275,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
275,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
275,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
275,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
276,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
276,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
276,3,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
276,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
276,5,Recall phenomenon,Skin procedural complications,Procedural related injuries and complications NEC,Inj&P,N
276,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
277,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
278,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
279,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
279,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
280,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
281,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
281,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
281,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
282,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
282,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
283,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
283,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
283,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
285,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
285,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
285,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
285,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
285,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
285,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
286,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
286,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
286,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
286,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
287,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
288,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
288,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
289,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
289,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
290,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
290,2,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
290,3,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,Y
290,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
291,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
292,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
292,2,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
292,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
293,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
294,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
295,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
295,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
295,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
296,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
296,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
296,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
296,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
298,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
299,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
300,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
300,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
300,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
300,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
301,1,Acute myelomonocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
302,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
303,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
303,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
303,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
303,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
304,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
305,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
305,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
306,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
306,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
306,3,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
306,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
306,5,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
306,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
306,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
306,8,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
306,9,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
306,10,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
307,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
307,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
308,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
308,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
308,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
308,4,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
308,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
308,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
308,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
308,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
308,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
309,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
309,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
309,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
309,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
310,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
310,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
310,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
310,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
310,5,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
310,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
311,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
311,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
312,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
312,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
312,3,Headache,Headaches NEC,Headaches,Nerv,N
312,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
312,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
313,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
314,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
315,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
315,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
316,1,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
316,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
317,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
317,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
317,3,Computerised tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
317,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
317,5,Headache,Headaches NEC,Headaches,Nerv,N
317,6,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
317,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
317,8,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
317,9,Liver scan abnormal,Hepatobiliary imaging procedures,Hepatobiliary investigations,Inv,N
317,10,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
317,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,12,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
317,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
317,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
318,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
319,1,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
320,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
320,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
320,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
320,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
320,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
321,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
322,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
322,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
322,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
323,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
324,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
324,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
324,3,Headache,Headaches NEC,Headaches,Nerv,N
324,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
324,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
324,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
325,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
325,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
325,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
325,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
325,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
325,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
325,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
325,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
325,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
325,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
325,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
325,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
325,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
325,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
325,15,Tic,Tic disorders,Changes in physical activity,Psych,N
326,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
327,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
327,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
328,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
329,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
330,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
330,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
331,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
332,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
333,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
334,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
335,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
336,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
337,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
338,1,Deafness,Hearing losses,Hearing disorders,Ear,N
339,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
339,2,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
340,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
340,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
340,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
340,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
340,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
340,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
340,7,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
341,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
342,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
342,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
342,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
342,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
343,1,Debridement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
343,2,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
343,3,Oesophageal squamous cell carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
343,4,Oesophagectomy,Oesophageal therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
343,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
343,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
343,7,Skin lesion removal,Skin lesion excisions,Skin and subcutaneous tissue therapeutic procedures,Surg,N
343,8,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
343,9,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
344,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
345,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
345,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
346,1,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
346,2,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
346,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
346,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
347,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
348,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
348,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
348,3,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
348,4,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
348,5,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
348,6,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
348,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
348,8,Pupillary disorder,Pupil disorders,Ocular neuromuscular disorders,Eye,N
348,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
349,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
349,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
350,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
351,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
352,1,Dilatation intrahepatic duct acquired,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
352,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
352,3,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
353,1,Pneumococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
354,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
354,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
354,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
354,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
355,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
355,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
355,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
356,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
356,2,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
356,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
357,1,Fanconi syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
357,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
358,1,Human chorionic gonadotropin increased,Reproductive hormone analyses,Endocrine investigations (incl sex hormones),Inv,N
358,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
358,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
358,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
358,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
359,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
359,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
359,3,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
359,4,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
359,5,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
359,6,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
359,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
359,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
359,9,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
359,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
359,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
359,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
359,13,Non-Hodgkin's lymphoma unspecified histology aggressive,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
359,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
360,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
360,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
360,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
361,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
362,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
362,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
363,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
364,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
365,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
365,2,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
365,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
366,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
366,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
366,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
366,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
367,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
367,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
368,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
368,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
369,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
369,2,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
370,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
371,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
372,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
372,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
372,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
373,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
374,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
374,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
375,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
375,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
376,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
376,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
377,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
377,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
378,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
379,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
379,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
379,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
380,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
380,2,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
380,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
380,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
381,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
381,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
382,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
382,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
382,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
382,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
383,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
383,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
383,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
384,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
384,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
385,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
385,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
386,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
386,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
386,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
387,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
387,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
387,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
388,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
388,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
388,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
389,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
389,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
389,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
390,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
390,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
391,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
391,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
391,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
392,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
392,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
393,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
393,2,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
393,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
393,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
393,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
393,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
394,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
395,1,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
395,2,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
395,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
396,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
396,2,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
396,3,Erythropoiesis abnormal,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
396,4,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
396,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
397,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
397,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
397,3,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
397,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
397,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
397,6,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
397,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
397,9,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
397,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
397,11,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
397,12,Headache,Headaches NEC,Headaches,Nerv,N
397,13,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
397,14,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
397,15,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
397,16,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
397,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
397,18,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
397,19,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
397,20,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
397,21,Sterile pyuria,Genitourinary tract infections and inflammations NEC,Genitourinary tract disorders NEC,Renal,N
397,22,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
397,23,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,24,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
397,25,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
399,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
399,2,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
399,3,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
400,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
400,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
401,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
402,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
402,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
403,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
403,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
403,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
403,4,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
404,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
404,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
405,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
406,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
406,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
406,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
406,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
406,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
406,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
407,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
407,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
407,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
408,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
408,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
408,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
409,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
409,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
409,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
410,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
410,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
411,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
411,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
411,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
412,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
412,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
413,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
413,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
413,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
413,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
413,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
413,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
414,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
414,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
415,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
415,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
415,3,Implant site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
415,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
416,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
416,2,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
416,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
416,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
417,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
418,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
419,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
420,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
421,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
421,2,Blood electrolytes decreased,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
422,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
422,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
422,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
423,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
423,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
423,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
424,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
425,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
425,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
425,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
425,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
425,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
426,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
426,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
427,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
427,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
428,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
428,2,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
429,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
429,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
429,3,Stenotrophomonas sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
430,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
431,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
431,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
432,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
432,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
433,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
433,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
433,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
433,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
433,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
433,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
433,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
433,8,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
433,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
434,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
434,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
435,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
435,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
435,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
435,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
435,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
436,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
436,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
437,1,Acute graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
437,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
437,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
437,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
437,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
437,6,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
437,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
437,8,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
437,9,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
437,10,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
437,11,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
437,12,Peripheral T-cell lymphoma unspecified recurrent,Peripheral T-cell lymphomas NEC,Lymphomas non-Hodgkin's T-cell,Neopl,N
437,13,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
437,14,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
437,15,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
438,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
438,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
438,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
438,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
438,5,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
438,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
440,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
441,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
441,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
442,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
442,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
442,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
443,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
443,2,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
443,3,Small cell lung cancer,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
443,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,1,Primitive neuroectodermal tumour,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
445,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
445,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
445,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
445,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
445,5,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
445,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
445,7,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
445,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
445,9,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
445,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
446,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
447,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
448,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
448,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
449,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
449,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
449,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
449,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
449,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
449,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
449,7,Salivary gland cancer stage IV,Salivary gland neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
449,8,Small cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
449,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
450,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
450,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
451,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
451,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
452,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
453,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
453,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
454,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
454,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
454,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
454,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
455,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
455,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
455,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
455,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
455,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
456,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
456,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
456,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
457,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
458,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
458,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
459,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
459,2,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
459,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
460,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
460,2,Anaemia megaloblastic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
460,3,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
460,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
461,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
462,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,Y
462,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
463,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
464,1,Ewing's sarcoma recurrent,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
465,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
466,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
466,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
467,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
468,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
469,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
469,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
470,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
470,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
471,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
471,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
472,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
472,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
473,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
473,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
473,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
474,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
474,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
475,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
475,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
475,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
475,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
475,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
475,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
475,7,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
475,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
475,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
475,10,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
475,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
476,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
476,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
477,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
478,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
478,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
478,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
479,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
479,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
479,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
479,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
479,5,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,N
479,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
480,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
480,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
481,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
481,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
481,3,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
481,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
481,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
481,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
482,1,Blood electrolytes abnormal,Water and electrolyte analyses NEC,"Water, electrolyte and mineral investigations",Inv,N
482,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
483,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
484,1,Carotid artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
484,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
484,3,Headache,Headaches NEC,Headaches,Nerv,N
484,4,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
484,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
484,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
485,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
485,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
485,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
486,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
487,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
487,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
487,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
488,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
489,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
489,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
490,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
491,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
492,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
492,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
492,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
492,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
493,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
493,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
493,3,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
493,4,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
494,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
494,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
494,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
494,4,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
495,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
496,1,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
496,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
496,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
497,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
498,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
499,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
500,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
500,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
501,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
501,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
501,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
501,4,Glioma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
501,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
502,1,Laryngeal cancer,Laryngeal neoplasms malignant,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
502,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
503,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
503,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
503,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
504,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
505,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
505,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
506,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
506,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
507,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
507,2,Renal abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
508,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
508,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
508,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
508,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
509,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
510,1,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
511,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
511,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
511,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
511,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
512,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
513,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
514,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
515,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
516,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
517,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
517,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
517,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
518,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
518,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
518,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
518,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
518,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
519,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
519,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
519,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
519,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
519,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
520,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
520,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
520,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
520,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
520,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
520,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
521,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
521,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
522,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
522,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
523,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
523,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
523,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
524,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
524,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
524,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
524,4,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
525,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
525,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
525,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
526,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
526,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
527,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
527,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
527,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
528,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
528,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
529,1,Aortic embolus,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
530,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
530,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
530,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
530,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
531,1,Ependymoma,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
531,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
531,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
532,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
532,2,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
533,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
533,2,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
534,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
534,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
534,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
535,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
535,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
535,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
536,1,Abdominal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
536,2,Biliary obstruction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
536,3,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
536,4,Retroperitoneal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
536,5,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
537,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
538,1,Ovarian failure,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
539,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
539,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
539,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
539,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
539,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
540,1,Hypogonadism,Endocrine abnormalities of gonadal function NEC,Endocrine disorders of gonadal function,Endo,N
540,2,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
541,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
541,2,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
542,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
542,2,Secretory adenoma of pituitary,Hormone secreting pituitary neoplasms,Endocrine neoplasms malignant and unspecified,Neopl,N
543,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
543,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
544,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
545,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
545,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
545,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
546,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
546,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
546,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
546,4,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
546,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
547,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
548,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
548,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
548,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
548,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
549,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
549,2,Subdural hygroma,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
549,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
550,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
550,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
550,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
550,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
551,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
551,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
552,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
552,2,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
552,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
552,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
552,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
553,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
553,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
554,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
554,2,Endocarditis candida,Candida infections,Fungal infectious disorders,Infec,N
554,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
554,4,Shunt malfunction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
555,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
555,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
555,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
555,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
555,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
556,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
556,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
557,1,Decorticate posture,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
557,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
557,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
557,4,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
558,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
558,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
558,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
558,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
558,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
558,6,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
558,7,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
558,8,Testicular germ cell cancer metastatic,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
558,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
559,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
559,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
559,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
559,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
559,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
559,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
559,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
559,8,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
559,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
560,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
560,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
560,3,Complicated appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
560,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
560,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
560,6,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
560,7,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
561,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
561,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
561,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
562,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
562,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
562,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
562,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
562,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
563,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
563,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
564,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
565,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
566,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
566,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
567,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
568,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
568,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
569,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
569,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
569,3,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
570,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
571,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
572,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
573,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
573,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
574,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
575,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
575,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
575,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
575,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
575,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
575,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
575,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
575,8,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
575,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
576,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
576,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
577,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
578,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
578,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
578,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
579,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
579,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
580,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
580,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
581,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
581,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,1,Administration related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
582,2,Autonomic nervous system imbalance,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
582,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,4,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
582,5,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
583,1,Glioneuronal tumour,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
583,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
584,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
584,2,Neuroblastoma,Nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
584,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
585,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
585,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
586,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
586,2,Rhabdoid tumour,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
587,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
587,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
587,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
587,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
587,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
587,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
588,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
589,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
589,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
590,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
590,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
590,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
591,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
592,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
593,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
593,2,Umbilical hernia,Umbilical hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
594,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
594,2,Trisomy 21,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
595,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
595,2,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
596,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
597,1,5-hydroxyindolacetic acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
597,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
597,3,Blood gastrin increased,"Gastrointestinal, pancreatic and APUD hormone analyses",Endocrine investigations (incl sex hormones),Inv,N
597,4,Bone loss,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
597,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
597,6,Borderline ovarian tumour,Female reproductive neoplasms unspecified malignancy,Reproductive neoplasms female malignant and unspecified,Neopl,N
597,7,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
597,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
597,9,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
597,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
597,11,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
597,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
597,13,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
597,14,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
597,15,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
597,16,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
597,17,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
597,18,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
597,19,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
597,20,Pelvic mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
597,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
597,22,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
597,23,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
597,24,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
597,25,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
597,26,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
598,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
598,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
598,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
599,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
599,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
599,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
600,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
600,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
601,1,Burkitt's lymphoma recurrent,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
601,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
602,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
602,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
603,1,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
603,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
603,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
604,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
605,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
605,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
605,3,Megacolon,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
606,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
606,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
607,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
608,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
608,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
609,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
609,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
610,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
610,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
611,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
611,2,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
611,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
611,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
611,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
611,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
611,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
611,8,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
612,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
613,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
613,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
613,3,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
613,4,Funnel chest acquired,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
613,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
613,6,Pleural fibrosis,Pleural conditions NEC,Pleural disorders,Resp,N
613,7,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
613,8,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
613,9,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
613,10,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
614,1,Deafness,Hearing losses,Hearing disorders,Ear,N
614,2,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
614,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
615,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
615,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
615,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
615,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,5,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
615,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
615,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
615,8,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
615,9,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
615,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
615,11,Still's disease,Rheumatoid arthropathies,Joint disorders,Musc,N
616,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
616,2,Excessive granulation tissue,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
616,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
616,4,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
616,5,Oesophageal mucosa erythema,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
616,6,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
616,7,Oesophageal stenosis,Oesophageal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
616,8,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
616,9,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
617,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
617,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
617,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
617,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
617,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
617,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
617,8,Natural killer-cell lymphoblastic lymphoma,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
617,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
617,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
618,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
619,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
619,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
620,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
620,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
620,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
621,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
622,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
623,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
624,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
624,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
624,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
624,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
624,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
624,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
624,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
624,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
624,9,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
624,10,Testicular germ cell cancer metastatic,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
624,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
625,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
625,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
626,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
626,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
627,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
627,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
627,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
627,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
627,5,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
627,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
628,1,High-grade B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
628,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
628,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
628,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
628,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
628,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
628,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
629,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
630,1,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
631,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
631,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
632,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
633,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
634,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
634,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
634,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
634,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
634,5,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
635,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
635,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
635,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
635,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
635,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
636,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
636,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
636,3,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
637,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
637,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
637,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
637,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
637,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
638,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
639,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
639,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
640,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
641,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
641,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
642,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
642,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
643,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
644,1,Anastomotic complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
644,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
645,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
647,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
648,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
649,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
649,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
649,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
650,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
650,2,Ovarian germ cell teratoma stage I,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
651,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
651,2,Ovarian germ cell teratoma stage I,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
652,1,Ovarian germ cell teratoma,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
653,1,Ovarian germ cell teratoma,Ovarian germ cell neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
654,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
655,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
656,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
656,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
656,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
656,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
656,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
656,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
656,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
656,8,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
656,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
657,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
657,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
657,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
658,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
658,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
658,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
659,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
659,2,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
659,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
659,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
659,5,Intracranial haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
659,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
659,7,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
659,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
660,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
661,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
661,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
661,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
661,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
662,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
662,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
662,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
663,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
663,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
664,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
665,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
666,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
667,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
668,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
668,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
669,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
670,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
670,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
671,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
673,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
673,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,1,Cerebellar haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
674,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
674,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
674,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
674,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
674,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
675,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
676,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
676,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
677,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
677,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
678,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
678,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
679,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
679,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
680,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
680,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
681,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
682,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
682,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
683,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
683,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
684,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
685,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
685,2,T-cell type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
685,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
686,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
686,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
686,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
686,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
686,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
687,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
687,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
687,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
687,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
687,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
687,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
689,1,Metastases to the mediastinum,Metastases to specified sites,Metastases,Neopl,N
689,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
689,3,Thymus enlargement,Thymus disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
690,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
690,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
690,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
690,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
690,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
690,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
691,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
692,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
692,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
693,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
693,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
693,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
693,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
693,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
693,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
693,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
693,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
693,9,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
693,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
694,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
695,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
696,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
696,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
696,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
696,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
697,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
697,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
697,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
697,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
697,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
697,6,Respiratory tract haemorrhage,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
697,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
698,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
698,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
698,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
698,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
698,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
698,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
699,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
699,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
699,3,Extrapyramidal disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
699,4,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
699,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
700,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
701,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
702,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
702,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
703,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
703,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
704,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
705,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
705,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
705,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
705,4,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
706,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
706,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
707,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
707,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
707,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
708,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
708,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
709,1,Gastroenteritis cryptosporidial,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
709,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
709,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
709,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
709,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
710,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
710,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
710,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
710,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
710,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
711,1,Malignant pleural effusion,Pleural neoplasms,Pleural disorders,Resp,N
711,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
712,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
712,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
712,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
713,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
713,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
713,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
713,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
713,5,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
713,6,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
713,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
713,8,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
713,9,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
713,10,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
713,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
713,12,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
713,13,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
713,14,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
713,15,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
713,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
714,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
714,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
715,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
715,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
715,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
715,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
715,5,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
715,6,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
715,7,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
715,8,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
715,9,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
715,10,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
715,11,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
715,12,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
715,13,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
715,14,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
715,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
715,16,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
715,17,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
715,18,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
715,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
716,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
716,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
717,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
717,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
717,3,Metastases to pelvis,Metastases to specified sites,Metastases,Neopl,N
717,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
718,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
718,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
718,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
718,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
718,5,Metastases to pelvis,Metastases to specified sites,Metastases,Neopl,N
718,6,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
718,7,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
719,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
719,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
719,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
719,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
719,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
720,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
720,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
720,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
720,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
721,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
721,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
721,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
721,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
721,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
721,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
722,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
722,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
722,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
722,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
722,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
722,7,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
722,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
723,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
723,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
724,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
724,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
725,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
725,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
726,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
726,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
726,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
727,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
728,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
728,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
729,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
730,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
730,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
731,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
731,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
731,3,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
731,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
731,5,Metastases to muscle,Metastases to specified sites,Metastases,Neopl,N
731,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
732,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
733,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
733,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
734,2,Bone infarction,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
734,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
734,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
734,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
734,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
735,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
736,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
736,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
736,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
737,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
737,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
737,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
737,4,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
737,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
738,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
738,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
739,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
739,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
739,3,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
739,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
739,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
739,6,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
740,1,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
741,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
741,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
742,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
743,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
743,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
743,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
743,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
743,5,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
743,6,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
743,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
743,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
743,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
743,10,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
743,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
743,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
743,13,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
743,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
743,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
743,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
743,17,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
743,18,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
743,19,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
743,20,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
743,21,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
743,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
744,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
745,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
745,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
746,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
746,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
746,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
746,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
746,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
747,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
747,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
748,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
749,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
749,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
750,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
751,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
752,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
753,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
754,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
755,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
755,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
756,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
756,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
757,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
757,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
758,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
759,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
759,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
759,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
759,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
759,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
759,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
759,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
759,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
759,9,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
759,10,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
759,11,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
759,12,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
759,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
759,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
759,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
759,16,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
759,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
760,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
760,2,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
761,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
762,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
763,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
763,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
763,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
763,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
763,5,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
763,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
763,7,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
763,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
763,9,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
764,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
764,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
764,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
764,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
764,5,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
764,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
764,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
764,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
764,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
764,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
764,11,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
765,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
765,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
765,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
765,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
765,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
765,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
765,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
765,8,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
765,9,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
765,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
765,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
766,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
766,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
766,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
766,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
766,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
766,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
766,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
766,8,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
766,9,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
766,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
766,11,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
766,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
767,1,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
767,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
768,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
768,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
768,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
768,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
768,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
768,6,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
769,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
770,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
770,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
770,3,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
770,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
770,5,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
771,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
771,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
772,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
773,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
773,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
773,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
773,4,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
773,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
773,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
773,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
773,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
773,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
773,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
774,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
774,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
774,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
774,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
774,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
774,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
774,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
774,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
774,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
775,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
776,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
777,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
778,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
778,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
779,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
780,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
781,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
782,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
782,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
783,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
783,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
783,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
784,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
784,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
784,3,Product preparation error,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
784,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
784,5,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
784,6,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
785,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
785,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
786,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
786,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
786,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
786,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
786,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
786,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
786,7,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
787,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
787,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
788,1,Acute myeloid leukaemia recurrent,Leukaemias acute myeloid,Leukaemias,Neopl,N
788,2,Acute myeloid leukaemia refractory,Leukaemias acute myeloid,Leukaemias,Neopl,N
788,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
788,4,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
788,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
788,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
789,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
789,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
790,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
790,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
790,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
791,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
791,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
791,3,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
792,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
792,2,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
793,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
793,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
793,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
793,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
793,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
793,6,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
793,7,Restrictive cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
793,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
793,9,Systolic dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
793,10,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
794,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
794,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
795,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
795,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
795,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
795,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
795,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
796,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
797,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
797,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
797,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
797,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
797,6,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
797,7,Headache,Headaches NEC,Headaches,Nerv,N
797,8,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
797,9,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
797,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
797,11,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
797,12,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
797,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
797,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
797,15,Rectal prolapse,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
797,16,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
797,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
798,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
798,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
798,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
799,1,Headache,Headaches NEC,Headaches,Nerv,N
799,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
799,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
799,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
800,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
800,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
800,3,Necrosis ischaemic,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
800,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
801,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
801,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
802,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
802,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
802,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
802,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
802,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
802,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
802,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
802,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
802,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
803,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
804,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
804,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
804,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
804,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
804,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
804,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
804,7,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
804,8,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
804,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
804,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
804,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
804,12,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
804,13,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
804,14,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
804,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
804,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
804,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
804,18,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
804,19,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
804,20,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
804,21,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
804,22,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
804,23,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
804,24,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
804,25,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
804,26,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
804,27,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
804,28,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
804,29,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
804,30,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
804,31,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
805,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
805,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
806,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
806,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
806,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
806,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
806,5,Transfusion-related circulatory overload,Transfusion related complications,Procedural related injuries and complications NEC,Inj&P,N
806,6,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
807,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
808,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
808,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
808,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
809,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
810,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
811,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
812,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
813,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
814,1,Acquired gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
814,2,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
814,3,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
815,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
815,2,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
815,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
816,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
816,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
816,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
816,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
816,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
816,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
816,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
817,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
818,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
819,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
819,2,Clonal haematopoiesis,Haematological disorders,Haematological disorders NEC,Blood,N
820,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
821,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
821,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
821,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
822,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
823,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
824,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
824,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
824,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
824,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
824,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
824,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
825,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
825,2,Ovarian cancer recurrent,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
826,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
826,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
826,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
827,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
827,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
827,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
827,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
827,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
827,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
827,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
827,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
827,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
828,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
829,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
829,2,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
830,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
831,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
831,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
831,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
832,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
832,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
832,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
832,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
832,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
832,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
832,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
832,8,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
832,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
833,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
834,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
834,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
835,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
835,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
836,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
837,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
837,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
838,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
839,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
840,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
841,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
842,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
843,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
843,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
844,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
845,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
846,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
846,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
847,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
847,2,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
847,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
847,4,Herpes zoster meningoencephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
847,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
847,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
848,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
848,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
848,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
849,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
850,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
850,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
850,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
851,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
851,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
851,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
852,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
852,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
852,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
853,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
854,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
854,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
855,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
855,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
856,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
856,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
857,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
858,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
859,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
859,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
859,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
860,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
861,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
861,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
861,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
861,4,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
862,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
863,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
864,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
865,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
865,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
866,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
866,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
867,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
867,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
867,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
867,4,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
867,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
867,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
868,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
868,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
868,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
868,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
868,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
868,6,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
869,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
869,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
869,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
870,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
870,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
870,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
870,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
870,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
870,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
870,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
870,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
870,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
871,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
872,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
872,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
872,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
872,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
872,5,Product used for unknown indication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
872,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
873,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
873,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
873,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
873,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
874,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
875,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
876,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
876,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
876,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
877,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
877,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
877,3,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
877,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
878,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,2,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
879,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
879,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
879,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
879,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
880,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
882,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
882,2,Metastatic renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
882,3,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
883,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
883,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
884,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
884,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
885,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
885,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
885,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
885,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
885,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
886,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
886,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
887,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
887,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
888,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
888,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
888,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
889,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
889,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
890,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
890,2,T-cell lymphoma refractory,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
891,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
891,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
891,3,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
891,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
891,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
891,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
891,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
891,8,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
891,9,Testicular germ cell tumour mixed stage II,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
891,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
891,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
892,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
892,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
892,3,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
893,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
894,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
895,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
896,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
896,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
896,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
897,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
898,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
899,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
900,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
900,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
900,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
900,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
900,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
900,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
901,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
902,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
903,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
903,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
903,3,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
903,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
903,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
903,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
903,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
903,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
903,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
903,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
903,11,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
903,12,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
903,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
903,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
903,15,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
903,16,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
903,17,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
903,18,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
903,19,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
903,20,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
903,21,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
903,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
903,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
903,24,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
903,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
903,26,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
903,27,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
903,28,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
903,29,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
903,30,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
903,31,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
904,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
904,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
904,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
904,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
904,5,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
904,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
904,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
904,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
904,9,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
904,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
905,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
906,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
906,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
907,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
908,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
908,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
908,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
908,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
908,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
908,6,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
908,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
909,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
910,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
911,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
912,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
913,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
913,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
913,3,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
913,4,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
913,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
913,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
913,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
913,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
913,9,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
913,10,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
913,11,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
913,12,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
913,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
913,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
913,15,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
913,16,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
913,17,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
913,18,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
913,19,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
913,20,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
913,21,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
913,22,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
913,23,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
913,24,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
913,25,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
913,26,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
913,27,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
913,28,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
913,29,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
913,30,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
913,31,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
914,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
914,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
915,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
915,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
915,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
915,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
916,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
916,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
917,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
917,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
917,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
917,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
917,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
917,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
917,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
917,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
918,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
918,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
919,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
920,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
920,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
920,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
920,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
920,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
920,6,Death,Death and sudden death,Fatal outcomes,Genrl,N
920,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
920,8,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
920,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
920,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
920,11,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
920,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
920,13,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
920,14,Headache,Headaches NEC,Headaches,Nerv,N
920,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
920,16,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
920,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
920,18,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
920,19,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
920,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
920,21,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
920,22,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
920,23,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
920,24,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
920,25,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
920,26,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
920,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
921,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
921,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
922,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
922,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
923,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
923,2,Deafness,Hearing losses,Hearing disorders,Ear,N
923,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
923,4,Weight abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
924,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
924,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
924,3,Headache,Headaches NEC,Headaches,Nerv,N
924,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
925,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
925,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
925,3,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
925,4,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
925,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
925,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
925,7,Tumour embolism,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
926,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
926,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
926,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
926,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
927,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
927,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
928,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
928,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
928,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
929,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
929,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
929,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
930,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
931,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
931,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
931,3,Headache,Headaches NEC,Headaches,Nerv,N
931,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
931,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
932,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
932,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
933,1,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
933,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
933,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
933,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
933,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
933,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
933,7,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
933,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
933,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
934,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
934,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
934,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
935,1,Adrenocortical carcinoma,Adrenal neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
935,2,DNA mismatch repair protein gene mutation,Gene mutations and other alterations NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
935,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
936,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
936,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
936,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
937,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
938,1,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
938,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
939,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
939,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
940,2,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
940,3,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
940,4,Tumour embolism,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
941,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
941,2,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
942,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
942,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
943,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
943,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
943,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
944,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
944,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
944,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
945,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
945,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
945,3,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
945,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
946,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
947,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
947,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
947,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
948,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
948,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
948,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
949,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
949,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
949,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
950,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
950,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
950,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
950,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
951,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
951,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
951,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
951,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
951,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
952,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
952,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
953,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
953,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
954,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
955,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
956,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
956,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
956,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
956,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
956,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
956,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
956,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
957,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
957,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
958,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
958,2,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
958,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
959,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
960,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
961,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
961,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
961,4,Tumour excision,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
962,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
962,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
962,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
963,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
963,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
963,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
963,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
963,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
964,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
965,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
965,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
965,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
966,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
966,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
967,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
967,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
968,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
968,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
968,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
969,1,B-cell lymphoma recurrent,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
969,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
969,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
970,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
970,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
970,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
971,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
972,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
973,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
973,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
973,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
973,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
973,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
973,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
973,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
973,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
974,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
974,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
974,3,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
974,4,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
974,5,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
974,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
974,7,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
974,8,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
974,9,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
974,10,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
974,11,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
974,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
974,13,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
974,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
974,15,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
974,16,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
974,17,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
974,18,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
974,19,Viral haemorrhagic cystitis,Viral infections NEC,Viral infectious disorders,Infec,N
975,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
976,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
976,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
976,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
976,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
976,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
977,1,Meningitis pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
977,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
977,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
977,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
977,5,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
978,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
978,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
978,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
978,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
978,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
978,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
978,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
978,8,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
979,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
980,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
980,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
981,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
981,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
981,3,Crepitations,General signs and symptoms NEC,General system disorders NEC,Genrl,N
981,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
981,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
981,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
981,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
981,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
981,9,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
982,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
983,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
984,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
984,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
985,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
985,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
985,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
985,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
985,5,Headache,Headaches NEC,Headaches,Nerv,N
985,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
985,7,Intestinal prolapse,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
985,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
985,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
985,10,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
985,11,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
985,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
985,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
985,14,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
986,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
986,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
987,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
987,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
987,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
988,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
988,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
989,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
989,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
989,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
989,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
989,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
989,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
990,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
991,1,Infantile vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
991,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
991,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
991,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
992,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
993,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
993,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
994,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
994,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
994,3,Neurological decompensation,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
995,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
995,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
